, /PRNewswire/ — On Point Legal Leads, a leading provider of mass tort leads and signed intake retainers, is excited to announce the launch of its latest comprehensive guide, Depo-Provera: Litigation Controversial Safety Warnings.
This in-depth analysis sheds light on the critical health and legal issues surrounding Depo-Provera, empowering legal professionals, patients, and industry stakeholders with essential information.
The guide provides extensive insights into:
- The health risks associated with Depo-Provera, including a significant increase in meningioma risk as highlighted by recent studies.
- Disparities in Pfizer’s international safety warnings, including meningioma risk information provided in Europe and Canada but not in the U.S.
- The expected scope of litigation, with projections for Multidistrict Litigation (MDL) in 2025 involving an estimated 30,000 cases.
Key findings from the guide include:
- Depo-Provera users are 5.55 times more likely to develop meningiomas than non-users, according to a 2024 British Medical Journal study.
- Since its FDA approval in 1992, Depo-Provera has been used by over a quarter of …